Halozyme Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 17.57 M | $839.84 M | 0.78% | 13.85% |
| VANGUARD GROUP INC | 02/11/2025 | 13.28 M | $635.00 M | 3.00% | 10.47% |
| SNYDER CAPITAL MANAGEMENT L P | 02/14/2025 | 4.17 M | $199.29 M | 2.59% | 3.29% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 3.07 M | $146.70 M | -9.97% | 2.42% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.06 M | $146.53 M | 0.13% | 2.42% |
| MACQUARIE GROUP LTD | 02/14/2025 | 2.91 M | $138.91 M | -3.50% | 2.29% |
| JPMORGAN CHASE & CO | 02/12/2025 | 2.39 M | $114.15 M | -16.66% | 1.88% |
| INVESCO LTD. | 02/13/2025 | 2.37 M | $113.52 M | 24.21% | 1.87% |
| CONGRESS ASSET MANAGEMENT CO /MA | 01/30/2025 | 1.96 M | $93.69 M | -19.47% | 1.54% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.93 M | $92.45 M | 2.53% | 1.52% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.85 M | $88.48 M | -6.28% | 1.46% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.78 M | $85.25 M | 0.55% | 1.41% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 1.75 M | $83.46 M | -0.94% | 1.38% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 1.53 M | $73.17 M | -0.56% | 1.21% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 1.51 M | $72.22 M | -24.87% | 1.19% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 1.37 M | $65.65 M | -56.18% | 1.08% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 1.37 M | $65.60 M | -11.52% | 1.08% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 01/28/2025 | 1.35 M | $64.40 M | -0.94% | 1.06% |
| NORGES BANK | 02/12/2025 | 1.26 M | $60.05 M | 100.00% | 0.99% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.22 M | $58.25 M | -4.11% | 0.96% |
| GROUPAMA ASSET MANAGMENT | 02/12/2025 | 1.20 M | $1.30 M | 0.00% | 0.95% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/12/2025 | 992,887 | $47.47 M | 141.34% | 0.78% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 980,870 | $46.90 M | -0.83% | 0.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 02/14/2025 | 887,852 | $42.45 M | 7.81% | 0.70% |
| BOSTON TRUST WALDEN CORP | 01/24/2025 | 874,081 | $41.79 M | 28.05% | 0.69% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 866,366 | $41.42 M | 1.77% | 0.68% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 859,572 | $41.10 M | -1.97% | 0.68% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 831,414 | $39.75 M | 171.16% | 0.66% |
| EPOCH INVESTMENT PARTNERS, INC. | 02/13/2025 | 778,311 | $37.21 M | -8.78% | 0.61% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 759,843 | $36.33 M | -9.30% | 0.60% |
| CAPITAL WORLD INVESTORS | 02/13/2025 | 748,230 | $35.77 M | 100.00% | 0.59% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 716,246 | $34.24 M | 1.75% | 0.56% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 702,085 | $33.57 M | 28.78% | 0.55% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 650,982 | $31.12 M | 86.61% | 0.51% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 650,751 | $31.11 M | 59.96% | 0.51% |
| LSV ASSET MANAGEMENT | 02/13/2025 | 631,061 | $30.17 M | 0.04% | 0.50% |
| UBS GROUP AG | 02/14/2025 | 618,774 | $29.58 M | 74.04% | 0.49% |
| ROYAL BANK OF CANADA | 02/14/2025 | 517,823 | $24.76 M | -0.61% | 0.41% |
| HANDELSBANKEN FONDER AB | 02/03/2025 | 516,469 | $24.69 M | -73.77% | 0.41% |
| BANK OF MONTREAL /CAN/ | 02/13/2025 | 469,781 | $22.46 M | -24.92% | 0.37% |
| MIZUHO MARKETS AMERICAS LLC | 02/11/2025 | 467,283 | $22.34 M | 24.46% | 0.37% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 456,774 | $21.84 M | 100.00% | 0.36% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 441,268 | $21.10 M | 14.88% | 0.35% |
| BI ASSET MANAGEMENT FONDSMAEGLERSELSKAB A/S | 02/13/2025 | 427,207 | $20.43 M | 45.11% | 0.34% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 414,719 | $19.83 M | 28.00% | 0.33% |
| RHUMBLINE ADVISERS | 01/30/2025 | 410,508 | $19.63 M | 1.44% | 0.32% |
| GRANITE INVESTMENT PARTNERS, LLC | 02/13/2025 | 409,281 | $19.57 M | -6.83% | 0.32% |
| BOSTON PARTNERS | 02/11/2025 | 407,984 | $19.95 M | -28.67% | 0.32% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2025 | 394,026 | $18.84 M | 8.09% | 0.31% |
| RETIREMENT SYSTEMS OF ALABAMA | 01/27/2025 | 390,082 | $18.65 M | 0.21% | 0.31% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Halozyme Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 695 institutional investors and hedge funds held shares of Halozyme Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 17.57 M
VANGUARD GROUP INC: 13.28 M
SNYDER CAPITAL MANAGEMENT L P: 4.17 M
ALLIANCEBERNSTEIN L.P.: 3.07 M
GEODE CAPITAL MANAGEMENT, LLC: 3.06 M
MACQUARIE GROUP LTD: 2.91 M
97.47% of Halozyme Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 162.39 M shares in the last 24 months. This purchase volume represents approximately $8.20 B in transactions.